FDA Approves Lymphoseek to Identify Cancer Spread in Head and Neck

June 16, 2014 10:16 AM

7 0

Lymphoseek injection, manufactured by Navidea Biopharmaceuticals, was first approved in March 2013 for lymphatic mapping procedures of patients diagnosed with breast cancer or melanoma. Doctors inject it to patients to trace the lymph nodes that drain the primary tumor. Tracing the lymph nodes could help doctors decide whether to perform a surgery to remove the tumor or not.

Lymphoseek injection, manufactured by Navidea Biopharmaceuticals, was first approved in March 2013 for lymphatic mapping procedures of patients diagnosed with breast cancer or melanoma. Doctors inject it to patients to trace the lymph nodes that drain the primary tumor. Tracing the lymph nodes could...

Read more

To category page

Loading...